[Circadian behaviour of host versus tumour outcome. A review].
The authors reviewed experimental and clinical data emphasizing the importance for host to keep a reference circadian rythmicity. This assessment seems true both in the cancerogenesis phase, as well in the active phase of tumoural disease.
Focan
C
C
Département de médecine interne, oncologie, CHC - Clinique Saint-Joseph, rue de Hesbaye 75, 4000 Liège, Belgique. christian.focan@CHC.be
Lévi
F
F
Innominato
P
P
D001066:Appetite; D002940:Circadian Rhythm / Q000502:physiology*; D005221:Fatigue; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy*; D012919:Social Behavior; D016896:Treatment Outcome